References
1. Voigtländer L, Seiffert M. Expanding TAVI to Low and Intermediate Risk Patients. Front Cardiovasc Med. 2018;5:7-12.
2. Rahimtoola SH. The problem of valve prosthesis mismatch. Circulation 1978; 58:20-4.
3. Dayan V Vignolo G Soca G Paganini JJ Brusich D Pibarot P. Predictors and outcomes of prosthesis patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 2016;9:924–33.
4. Fallon JM DeSimone JP Brennan JM O’Brien S Thibault DP DiScipio AW et al.  The incidence and consequence of prosthesis-patient mismatch after surgical aortic valve replacement. Ann Thorac Surg 2018;106:14–22.
5. Pibarot P Clavel MA. Prosthesis-patient mismatch after transcatheter aortic valve replacement: it is neither rare nor benign. J Am Coll Cardiol 2018;72:2712–6.
6. Head S Mokhles M Osnabrugge R Pibarot P Mack MJ Takkenberg J et al.  The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27,186 patients with 133,141 patient-years. Eur Heart J 2012;33:1518–29.
7. Sa M de Carvalho MMB Sobral Filho DC Cavalcanti LRP Rayol SDC Diniz RGS et al. Surgical aortic valve replacement and patient-prosthesis mismatch: a meta-analysis of 108 182 patients. Eur J Cardiothorac Surg 2019;56:44–54.
8. Thyregod HG Steinbruchel DA Ihlemann N Ngo TA Nissen H Kjeldsen BJ et al.  No clinical   effect of prosthesis-patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid- term follow-up: an analysis from the NOTION trial. Eur J Cardiothorac Surg 2016;50:721–8.
9. Pibarot P Weissman NJ Stewart WJ Hahn RT Lindman BR McAndrew T et al.  Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis- A PARTNER trial cohort A analysis. J Am Coll Cardiol 2014;64:1323–34.
10. Pibarot P. The CHOICE between self-expanding and balloon expandable valves for transcatheter aortic valve replacement. J Am Coll Cardiol Intv 2018; 11:2519-22
11. Herrmann HC Daneshvar SA Fonarow GC Stebbins A Vemulapalli S Desai ND et al. Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS/ACC TVT registry. J Am Coll Cardiol 2018;72:2701–11.
12. Ewe SH Muratori M Delgado V Pepi M Tamborini G Fusini L et al.  Hemodynamic and clinical impact of prosthesis-patient mismatch after transcatheter aortic valve implantation. J Am Coll Cardiol 2011;58:1910–8.
13. Thyregod HG Steinbruchel DA Ihlemann N Ngo TA Nissen H Kjeldsen BJ et al.  No clinical effect of prosthesis-patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid-term follow-up: an analysis from the NOTION trial. Eur J Cardiothorac Surg 2016;50:721–8.
14. Tzikas A Piazza N Geleijnse ML Van Mieghem N Nuis RJ Schultz C et al.  Prosthesis-patient mismatch after transcatheter aortic valve implantation with the medtronic CoreValve system in patients with aortic stenosis. Am J Cardiol 2010;106:255–60.
15. Miyasaka M Tada N Taguri M Kato S Enta Y Otomo T et al. Incidence, predictors, and clinical impact of prosthesis-patient mismatch following transcatheter aortic valve replacement in Asian Patients: the OCEAN-TAVI Registry. JACC Cardiovasc Interv 2018;11:771–80.
16. Ternacle J, Guimaraes L, Vincent F, et al. Reclassification of prosthesis-patient mismatch after transcatheter aortic valve replacement using predicted vs. measured indexed effective orifice area.European Heart Journal Cardiovascular Imaging . Published online September 30, 2020. doi:10.1093/ehjci/jeaa235